EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

Altered T-cell reactivity in the early stages of Alzheimer's disease

Chiara Rickenbach, Anna Mallone, Lars Häusle, Larissa Frei, Sarina Seiter, Colin Sparano, Tunahan Kirabali, Kaj Blennow, Henrik Zetterberg iD, Maria Teresa Ferretti, Luka Kulic, Christoph Hock and 4 more

Brain · 2025-09-03 · 148 (9) · 3364-3378

DOI: 10.1093/brain/awaf167 ↗

At a glance

Journal article in Brain, published online on 2025-05-05. Written by Chiara Rickenbach and 15 co-authors. Institution: Institute for Regenerative Medicine-IREM, University of Zurich, 8952 Schlieren, Switzerland. Major MEDLINE topics: Alzheimer Disease, T-Lymphocytes. Cited 34 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: University of Zurich, Synapsis Foundation-Dementia Research Switzerland, Swiss National Science Foundation.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The adaptive immune system and neurodegenerative Alzheimer's disease (AD) are intertwined in multiple ways. Recent studies have reported alterations of the adaptive immune system in early AD stages, such as preclinical AD and mild cognitive impairment (MCI) due to AD. However, the identity of specific antigenic targets and whether the respective response is beneficial or detrimental during disease progression are still open questions. Herein, we describe cross-sectional analyses of blood and CSF from three different study populations covering early AD stages. We employed high-dimensional mass cytometry, single-cell RNA-sequencing, ex vivo T-cell secretome analysis, and antigen presentation assays to achieve a comprehensive characterization of adaptive immune cell populations. Our results show that subjects at the stage of asymptomatic, preclinical AD can mount a CD4+ T helper cell response towards amyloid-β peptide and display an early enrichment of CD8+ T effector memory cells re-expressing CD45RA (TEMRA cells) in CSF, combined with a less immunosuppressive gene signature of peripheral regulatory T cells. Conversely, in MCI we observed increased frequencies of CD8+ TEMRA/effector cells in the periphery characterized by a pro-inflammatory gene expression profile, and generally decreased antigen responsiveness. Our results demonstrate the complexity of adaptive immune changes in early AD and suggest that it may be beneficial to promote specific CD4+ T-cell responses in the preclinical stage, while in MCI it may be important to therapeutically target CD8+ T-cell responses if these prove to be harmful.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseT-LymphocytesHumansMaleFemaleAgedCross-Sectional StudiesCognitive DysfunctionAged, 80 and overAmyloid beta-PeptidesMiddle AgedCD4-Positive T-LymphocytesCD8-Positive T-Lymphocytes

Author keywords

AD biomarkersAlzheimer’s disease (AD)CyTOFT cellsantigen specificityscRNA-seq

Substances

Amyloid beta-Peptides

Authors and institutions

  • Institute for Regenerative Medicine-IREM, University of Zurich, 8952 Schlieren, Switzerland.
  • Institute of Microbiology, ETH Zurich, 8049 Zurich, Switzerland.
  • Institute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, S-43180 Mölndal, Sweden.
  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-43180 Mölndal, Sweden.
  • Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, 75013 Paris, France.

ORCID profiles: Henrik Zetterberg, Christoph Gericke

Funding

  • University of Zurich
  • Synapsis Foundation-Dementia Research Switzerland
  • Swiss National Science Foundation
  • Mäxi Foundation
  • Swedish Research Council
  • Swedish Alzheimer Foundation
  • Hjärnfonden
  • Swedish government

Cite

APA

Rickenbach, C., Mallone, A., Häusle, L., Frei, L., Seiter, S., Sparano, C., Kirabali, T., Blennow, K., Zetterberg, H., Ferretti, M. T., Kulic, L., Hock, C., Nitsch, R. M., Treyer, V., Gietl, A., & Gericke, C. (2025). Altered T-cell reactivity in the early stages of Alzheimer's disease. Brain, 148(9), 3364-3378. https://doi.org/10.1093/brain/awaf167

Vancouver

Rickenbach C, Mallone A, Häusle L, Frei L, Seiter S, Sparano C, et al. Altered T-cell reactivity in the early stages of Alzheimer's disease. Brain. 2025;148(9):3364-3378. doi:10.1093/brain/awaf167

BibTeX
@article{Rickenbach2025,
  author = {Rickenbach, Chiara and Mallone, Anna and Häusle, Lars and Frei, Larissa and Seiter, Sarina and Sparano, Colin and Kirabali, Tunahan and Blennow, Kaj and Zetterberg, Henrik and Ferretti, Maria Teresa and Kulic, Luka and Hock, Christoph and Nitsch, Roger M and Treyer, Valerie and Gietl, Anton and Gericke, Christoph},
  title = {Altered T-cell reactivity in the early stages of Alzheimer's disease},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {9},
  pages = {3364--3378},
  doi = {10.1093/brain/awaf167}
}
Start for free →